Target intelligence / Profile preview

Solute carrier family 38 member 9 (SLC38A9)

Target
SLC38A9
Molecular classification
Transporter, Transceptor (transporter and receptor-like signaling protein), Sodium-coupled amino acid transporter, Member of solute carrier family (SLC38), APC (Amino acid-polyamine-organocation) superfamily
01

Overview

SLC38A9 is a **lysosomal membrane protein** that functions as both an amino acid transporter and a nutrient sensor (“transceptor”) for the mTORC1 pathway[1][2][3]. It is a member of the **solute carrier 38 family** of sodium-coupled amino acid transporters and the larger APC superfamily[3]. SLC38A9 mediates low capacity, relatively low specificity influx of several polar and neutral amino acids, with a particular role as an arginine sensor. By physically interacting with the Ragulator and Rag GTPase complexes at the lysosome, SLC38A9 signals arginine sufficiency to mTORC1, thus promoting cellular growth and anabolic processes[2][6][7]. Its dual transport and signaling function is essential for lysosomal amino acid homeostasis and metabolic adaptation. SLC38A9 is also reported as upregulated in some cancers, including lung cancer, and emerging evidence suggests a possible role in sensing lysosomal cholesterol levels[7]. No specific clinically approved drugs are known to directly target SLC38A9 as of mid-2024.

Other names
Neutral amino acid transporter 9SNAT9Up-regulated in lung cancer 11URLC11FLJ90709Sodium-coupled neutral amino acid transporter 9
02

Mechanism of action

Transport of amino acids across lysosomal membrane (sodium-coupled) Sensors/signalers to Rag GTPases and Ragulator complex for mTORC1 activation in response to amino acid (especially arginine) and cholesterol levels

03

Biological functions

Amino acid transport (especially arginine, L-glutamine, leucine, tyrosine)Amino acid sensingActivation of mTORC1 signaling complex in response to amino acid levelsCholesterol sensing (emerging role)
04

Disease associations

Cancer (notably, up-regulated in lung cancer)mTORC1 pathway-associated diseasesPotential metabolic regulation in lysosomal disorders
05

Safety considerations

As a lysosomal transporter intimately linked to mTORC1 signaling and amino acid homeostasis, inhibition or modulation may impact cellular growth, autophagy, or metabolism, raising concerns for off-target or metabolic effects[2][6]
06

Biomarkers

Up-regulation in certain cancers (lung cancer) reported as a biomarker for malignancy or altered metabolic state[7]

Beyond the preview

Go deeper on Solute carrier family 38 member 9 (SLC38A9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 38 member 9 (SLC38A9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call